AN2 Therapeutics, Inc.
USD4.80
+0.12 (+2.56%)
CEO
Eric E. Easom
IPO Date
2022-03-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.85
Prev. Close
$4.68
Day Low
$4.79
Day High
$5.24
52W Low
$1.00
52W High
$6.91
Market Cap
$0.13B
Volume
0.26M
| 2,789 |
| $0.00 |
| 10 Jul 2026 | Martin Patricia A. | director | A-Award | Acquired | 766 | $0.00 |
| 10 Jul 2026 | Eizen Joshua M | See Remarks | S-Sale | Disposed | 5,945 | $4.17 |
| 2 Jun 2026 | Williams Sarah Joanne | Principal Accounting Officer | S-Sale | Disposed | 265 | $4.43 |
| 10 Apr 2026 | Aziz Kabeer | director | A-Award | Acquired | 3,775 | $0.00 |
| 10 Apr 2026 | Marks Gilbert Lynn | director | A-Award | Acquired | 3,775 | $0.00 |
| 10 Apr 2026 | Martin Patricia A. | director | A-Award | Acquired | 1,192 | $0.00 |
| 23 Mar 2026 | Day Lucy | Chief Financial Officer | A-Award | Acquired | 73,665 | $3.91 |
| 23 Mar 2026 | Day Lucy | Chief Financial Officer | D-Return | Disposed | 73,665 | $6.60 |